Tag
Tag: Regeneron
Update: Fifth US Antibody Patent Owned by UK Biotech Upheld in Regeneron Battle
Finnish Genetics Study Provides Clues for Treating Type 2 Diabetes
Dutch and US Biotechs Team Up Against HPV-related Cancer
Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer
Update: The EU Approval of Dupixent Might Bring its Pricing Polemic to Europe
Wind Blown into the Sails of New Asthma Drug With Positive Phase III Results
Checkpoint Inhibitor from Regeneron and Sanofi gets Priority After Breakup
Regeneron Cuts Sanofi Loose as Antibody Development Partner
UPDATE: EMA joins FDA in Approving Rheumatoid Arthritis Drug from Sanofi and Regeneron
Novartis Tops Ophthalmology Blockbuster Eylea in Phase III Trials
